{"organizations": [], "uuid": "8014ca06f59557812874cad147d79c0ff54f5f2d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-north-china-pharmaceutical-receive/brief-north-china-pharmaceutical-receives-gmp-certificate-idUSL4N1PY3ZQ", "country": "US", "domain_rank": 408, "title": "BRIEF-North China Pharmaceutical receives GMP certificate", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.995, "site_type": "news", "published": "2018-02-08T18:12:00.000+02:00", "replies_count": 0, "uuid": "8014ca06f59557812874cad147d79c0ff54f5f2d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-north-china-pharmaceutical-receive/brief-north-china-pharmaceutical-receives-gmp-certificate-idUSL4N1PY3ZQ", "ord_in_thread": 0, "title": "BRIEF-North China Pharmaceutical receives GMP certificate", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "gmp", "sentiment": "negative"}, {"name": "brief-north china pharmaceutical", "sentiment": "negative"}, {"name": "reuters) - north china pharmaceutical co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "hebei food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - North China Pharmaceutical Co Ltd\n* Says it received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration on Feb. 6\n* Certificate issued to powder-injection manufactured by the company and the valid period is until Jan. 17, 2023\nSource text in Chinese: goo.gl/RMHmLS\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/RMHmLS", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T18:12:00.000+02:00", "crawled": "2018-02-09T17:06:35.026+02:00", "highlightTitle": ""}